TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program May 10, 1974
TCL Archive Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress June 6, 1980
Institutions Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer October 25, 2021
